Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2021

View Archived Issues

Vaccine shows efficacy against Lyme disease in guinea pigs

Novel protein ACE2 1-618-DDC-ABD protects against lethal SARS-CoV-2 infection

Preclinical results presented on a novel conditionally activated IFN-alpha INDUKINE molecule

Stanford researchers identify means of targeting RBM20 for ameliorating diseased cardiomyocytes

PCC-1, an orally active HPK1 inhibitor with strong antitumor activity

Novel STING agonist RVU-27065 shows potency in EMT6 breast cancer model

Medshine Discovery discloses new MAPK inhibitors

p53-PHLDA3-Akt signaling as novel therapeutic target in heart failure

Gasherbrum Bio patents GLP-1 receptor agonists

Innate checkpoint inhibitor ASD-141 inhibits tumor growth in colon cancer models

GNT Biotech & Medicals presents new HDAC inhibitors

Betta Pharmaceuticals identifies PTPN11 inhibitors

Shanghai Licheng Biotechnology divulges CLRN3-targeting nucleic acids

Novel acute lung injury murine model unveils neuronal damage

TOTUM-854 prevents the development of experimental arterial hypertension

Abintus to use Memorial Sloan's 1XX technology with CAR-X products

CoImmune enters research collaboration with Yeda Research and Development on SIN technology

Emultech and Osteo-Pharma establish Bone-Tech joint venture for osteoarthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...